"Probiotics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Live microbial DIETARY SUPPLEMENTS which beneficially affect the host animal by improving its intestinal microbial balance. Antibiotics and other related compounds are not included in this definition. In humans, lactobacilli are commonly used as probiotics, either as single species or in mixed culture with other bacteria. Other genera that have been used are bifidobacteria and streptococci. (J. Nutr. 1995;125:1401-12)
| Descriptor ID |
D019936
|
| MeSH Number(s) |
G07.203.300.456.500 J02.500.456.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Probiotics".
Below are MeSH descriptors whose meaning is more specific than "Probiotics".
This graph shows the total number of publications written about "Probiotics" by people in this website by year, and whether "Probiotics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 3 | 1 | 4 |
| 2007 | 1 | 0 | 1 |
| 2008 | 6 | 2 | 8 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 0 | 3 |
| 2011 | 5 | 1 | 6 |
| 2012 | 1 | 1 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 0 | 2 |
| 2015 | 4 | 1 | 5 |
| 2016 | 2 | 4 | 6 |
| 2017 | 1 | 3 | 4 |
| 2018 | 3 | 3 | 6 |
| 2019 | 3 | 1 | 4 |
| 2020 | 2 | 3 | 5 |
| 2021 | 1 | 0 | 1 |
| 2022 | 3 | 1 | 4 |
| 2023 | 3 | 1 | 4 |
| 2024 | 1 | 3 | 4 |
| 2025 | 1 | 3 | 4 |
| 2026 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Probiotics" by people in Profiles.
-
Engineered probiotic Bifidobacterium for tumor-targeted pancreatic cancer therapy. Sci Adv. 2026 Jul 24; 12(30):eadz1388.
-
Microbial Therapeutics for the Prevention and Treatment of Food Allergy. J Allergy Clin Immunol Pract. 2026 04; 14(4):780-785.
-
A case of yogurt central line-associated bloodstream infection in a child with intestinal failure. Nutr Clin Pract. 2026 Jun; 41(3):968-973.
-
The Role of the Microbiome and the Neurovascular Unit. Surg Clin North Am. 2025 Oct; 105(5):857-869.
-
Reutericyclin, a specialized metabolite of Limosilactobacillus reuteri, mitigates risperidone-induced weight gain in mice. Gut Microbes. 2025 12; 17(1):2477819.
-
Lactobacillus rhamnosus GG induces STING-dependent IL-10 in intestinal monocytes and alleviates inflammatory colitis in mice. J Clin Invest. 2025 Feb 03; 135(3).
-
Regulation of immune responses to food by commensal microbes. Immunol Rev. 2024 09; 326(1):203-218.
-
Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies. Expert Opin Ther Targets. 2024 08; 28(8):669-687.
-
Skin as the target for allergy prevention and treatment. Ann Allergy Asthma Immunol. 2024 08; 133(2):133-143.
-
Probiotics in the Treatment of Inflammatory Bowel Diseases. Adv Exp Med Biol. 2024; 1449:135-142.